


Healthcare News Roundup: FDA
HSMN NewsFeed - 29 Sep 2016
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
Allergan Issues Statement on Namenda XR Patent Litigation Following Announcement of ANDA Approvals
HSMN NewsFeed - 22 Sep 2016
Sanaria(R) PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
Sanaria(R) PfSPZ Vaccine Against Malaria Receives FDA Fast Track Designation
HSMN NewsFeed - 20 Sep 2016
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
Lannett Announces Approval For Buprenorphine And Naloxone Sublingual Tablets, 2 mg/0.5 mg And 8 mg/2 mg
HSMN NewsFeed - 19 Sep 2016
FDA-Cleared Bed Linens Engineered to Reduce Development of Pressure Ulcers
FDA-Cleared Bed Linens Engineered to Reduce Development of Pressure Ulcers
HSMN NewsFeed - 19 Sep 2016
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
Medeon Biodesign Receives FDA 510(k) Clearance for Abclose(TM) - Laparoscopic Port Site Closure Device
HSMN NewsFeed - 15 Sep 2016
Varian Medical Systems Receives FDA 510(k) Clearance for Nexus DR Digital X-Ray Imaging System
Varian Medical Systems Receives FDA 510(k) Clearance for Nexus DR Digital X-Ray Imaging System
HSMN NewsFeed - 9 Sep 2016
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
HSMN NewsFeed - 7 Sep 2016
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
HSMN NewsFeed - 7 Sep 2016
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
FDA allows Phrixus’s IND for Carmeseal-MD(TM) (P-188 NF) in Duchenne muscular dystrophy (DMD)
HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
HSMN NewsFeed - 29 Aug 2016
Fortimedix Surgical Announces 510(k) Clearance for Innovative Single-port Surgical Platform
Fortimedix Surgical Announces 510(k) Clearance for Innovative Single-port Surgical Platform
HSMN NewsFeed - 25 Aug 2016
Mallinckrodt Receives FDA Fast-Track Designation for Synacthen(R) Depot IND Application
Mallinckrodt Receives FDA Fast-Track Designation for Synacthen(R) Depot IND Application
HSMN NewsFeed - 23 Aug 2016
ImPACT(R) is the First Concussion-Specific Medical Device to Receive FDA Clearance
ImPACT(R) is the First Concussion-Specific Medical Device to Receive FDA Clearance
HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
